HtrA Serine Peptidase 4 (HTRA4) (Middle Region) Peptide
Aperçu rapide pour HtrA Serine Peptidase 4 (HTRA4) (Middle Region) Peptide (ABIN8102811)
Antigène
Source
Application
-
-
Protein Region
- Middle Region
-
Fonction
- HTRA4 Peptide - middle region
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-HTRA4 antibody ( ARP55603_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- HTRA4 (HtrA Serine Peptidase 4 (HTRA4))
-
Sujet
-
Background Information: HTRA4 is a member of the HtrA family of proteases. The protein contains a putative signal peptide, an insulin growth factor binding domain, a Kazal protease inhibitor domain, a conserved trypsin domain and a PDZ domain. Based on studies on other related family members, this enzyme may function as a secreted oligomeric chaperone protease to degrade misfolded secretory proteins. Other human HtrA proteins have been implicated in arthritis, tumor suppression, unfolded stress response, apoptosis, and aging.
Alternative Symbols: FLJ90724
-
Poids moléculaire
- 51kDa
-
ID gène
- 203100
-
NCBI Accession
- NP_710159
-
UniProt
- P83105
Antigène
-